Page last updated: 2024-09-05

3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and Leukemia L 1210

3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin has been researched along with Leukemia L 1210 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acton, EM; Mosher, CW; Tong, GL; Wolgemuth, RL1
Courseille, C; Dautant, A; Langlois D'estaintot, B; Mondon, M; Précigoux, G; Saminadin, P1
Groth, G; Marquardt, H; Steinheider, G; Westendorf, J1

Other Studies

3 other study(ies) available for 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and Leukemia L 1210

ArticleYear
Intensely potent morpholinyl anthracyclines.
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:5

    Topics: Animals; Antibiotics, Antineoplastic; Doxorubicin; Drug Evaluation, Preclinical; Indicators and Reagents; Leukemia L1210; Leukemia P388; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Structure-Activity Relationship

1984
Release of the cyano moiety in the crystal structure of N-cyanomethyl-N-(2-methoxyethyl)-daunomycin complexed with d(CGATCG).
    European journal of biochemistry, 2000, Volume: 267, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Crystallography, X-Ray; Cyanides; Daunorubicin; DNA; Doxorubicin; Inhibitory Concentration 50; Leukemia L1210; Models, Molecular; Nucleic Acid Conformation

2000
Formation of DNA-adducts and induction of DNA-crosslinks and chromosomal aberrations by the new potent anthracycline antitumor antibiotics: morpholinodaunomycin, cyanomorpholinodaunomycin and cyanomorpholinoadriamycin.
    Cell biology and toxicology, 1985, Volume: 1, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Cells, Cultured; Chemical Phenomena; Chemistry; Chromosome Aberrations; Daunorubicin; DNA; DNA Repair; Doxorubicin; Leukemia L1210; Liver; Rats

1985